BridgeMD
New treatment option for Head and Neck Squamous Cell Carcinoma
Official title Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
ClinicalTrials.gov ID: NCT02678884
What this study is testing
What is 18-F FDG?
18-F FDG is an investigational medicine, being studied as a potential treatment for head and neck squamous cell carcinoma.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to see how useful the information provided from Positron Emission Tomography (PET) scans can be in the actual planning and delivery of radiation treatment to patients who have head and neck cancers. Patients participating in this study, will have (in addition to their routine tests) a PET scan before and during their radiation treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Non-nasopharynx head and neck mucosal squamous cell carcinoma
- Radiologically evident gross disease
- Radiotherapy alone for curative intent
- Age equal to or more than 18 years old
- To be eligible for the second study PET-CT scan: FDG avid tumour (or minimum SUV of 2.5) on the first study PET-CT scan
You likely can't join if
- Nasopharynx cancer
- H\&N SCC skin
- Distant metastases (already known or if found on baseline CT-thorax)
- Prior malignancy within the last 5 years (exclude non-H\&N SCC, BCC skin)
- Prior chemotherapy within the last 5 years or concurrent chemotherapy/EGFR inhibitors
- Prior head and neck radiotherapy
See the full eligibility criteria
- Non-nasopharynx head and neck mucosal squamous cell carcinoma
- Radiologically evident gross disease
- Radiotherapy alone for curative intent
- Age equal to or more than 18 years old
- To be eligible for the second study PET-CT scan: FDG avid tumour (or minimum SUV of 2.5) on the first study PET-CT scan
- Nasopharynx cancer
- H\&N SCC skin
- Distant metastases (already known or if found on baseline CT-thorax)
- Prior malignancy within the last 5 years (exclude non-H\&N SCC, BCC skin)
- Prior chemotherapy within the last 5 years or concurrent chemotherapy/EGFR inhibitors
- Prior head and neck radiotherapy
- Inability to lie supine for study duration
- Pregnancy
- Inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.